Annual Drug Patent Expirations for VIBERZI
Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.
Drug patent litigation for VIBERZI.
This drug has one hundred and twenty-seven patent family members in forty countries.
The generic ingredient in VIBERZI is eluxadoline. One supplier is listed for this compound. Additional details are available on the eluxadoline profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
